AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Troost, F. J
Right arrow Articles by Saris, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Troost, F. J
Right arrow Articles by Saris, W. H.
Agricola
Right arrow Articles by Troost, F. J
Right arrow Articles by Saris, W. H.
American Journal of Clinical Nutrition, Vol. 78, No. 5, 1018-1023, November 2003
© 2003 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects1,2,3

Freddy J Troost, Robert-Jan M Brummer, Jack R Dainty, Jurian A Hoogewerff, Vicky J Bull and Wim HM Saris

1 From the Department of Human Biology, NUTRIM, Maastricht University, Maastricht, Netherlands (FJT and WHMS); the Department of Gastroenterology, NUTRIM, University Hospital Maastricht, Maastricht, Netherlands (R-JMB); and the Institute of Food Research, Norwich, United Kingdom (JRD, JAH, and VJB).

Background: Iron supplements may inhibit intestinal zinc and copper uptake because these elements may compete for binding to a transporter molecule (divalent metal transporter 1) that is located on the apical side of the small intestinal epithelium.

Objective: We quantified the interaction between different amounts of administered iron and the absorption of zinc and copper in humans.

Design: Eleven subjects with an ileostomy [mean (± SD) age: 55 ± 9 y] ingested a stable-isotope-labeled zinc and copper solution containing 12 mg Zn (66Zn and 67Zn) and 3 mg Cu (65Cu) in the presence of 0, 100, or 400 mg Fe as ferrous gluconate on 3 respective test days. Subsequently, 1 mg 70Zn was injected intravenously. Subjects collected ileostomy effluent and urine for 24 h and 7 d, respectively. Zinc status and true zinc absorption were calculated from the urinary excretion of the zinc isotopes. Apparent copper absorption was calculated from ileostomy effluent excretion of the orally administered copper isotopes.

Results: Zinc status did not differ significantly between the 3 iron doses. Mean (± SEM) zinc absorption was significantly higher in the absence of iron than with the concomitant ingestion of 100 or 400 mg Fe (44 ± 22% compared with 26 ± 14% and 23 ± 6%, respectively; P < 0.05), whereas zinc absorption did not differ significantly between the 100- and 400-mg Fe doses. Apparent copper absorption was 48 ± 14%, 54 ± 26%, and 53 ± 7% in the presence of 0, 100, and 400 mg Fe, respectively, and did not differ significantly between the 3 iron doses.

Conclusion: Oral iron therapy may impair zinc absorption and thus zinc status in a dose-independent fashion but does not affect copper absorption.

Key Words: Ileostomy • zinc • copper • iron • zinc absorption • copper absorption • small intestine




This article has been cited by other articles:


Home page
Toxicol SciHome page
K.-S. Min, H. Ueda, T. Kihara, and K. Tanaka
Increased Hepatic Accumulation of Ingested Cd is Associated with Upregulation of Several Intestinal Transporters in Mice Fed Diets Deficient in Essential Metals
Toxicol. Sci., November 1, 2008; 106(1): 284 - 289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. J Harvey, J. R Dainty, W. J Hollands, V. J Bull, J. H Beattie, T. I Venelinov, J. A Hoogewerff, I. M Davies, and S. J Fairweather-Tait
Use of mathematical modeling to study copper metabolism in humans
Am. J. Clinical Nutrition, April 1, 2005; 81(4): 807 - 813.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
J. Boullata
Natural Health Product Interactions with Medication
Nutr Clin Pract, February 1, 2005; 20(1): 33 - 51.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. P. Pena-Rosas, M. C. Nesheim, M. N. Garcia-Casal, D. W. T. Crompton, D. Sanjur, F. E. Viteri, E. A. Frongillo, and P. Lorenzana
Intermittent Iron Supplementation Regimens Are Able to Maintain Safe Maternal Hemoglobin Concentrations during Pregnancy in Venezuela
J. Nutr., May 1, 2004; 134(5): 1099 - 1104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The American Society for Nutrition